| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 13.539 | 127.135 | 333.023 | 377.094 | 415.323 |
| Total Income - EUR | - | - | - | - | - | 14.935 | 131.518 | 338.786 | 377.308 | 415.327 |
| Total Expenses - EUR | - | - | - | - | - | 12.540 | 91.611 | 247.105 | 307.302 | 365.424 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 2.395 | 39.907 | 91.681 | 70.006 | 49.903 |
| Net Profit/Loss - EUR | - | - | - | - | - | 2.341 | 38.949 | 88.417 | 66.532 | 38.923 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 3 | 3 |
Check the financial reports for the company - Proelitis Center S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 4.516 | 72.970 | 100.325 | 326.485 | 493.324 |
| Current Assets | - | - | - | - | - | 7.525 | 12.981 | 36.093 | 79.096 | 9.768 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 2.853 | 3.866 | 32.801 | 70.285 | 3.744 |
| Cash | - | - | - | - | - | 4.672 | 9.115 | 3.292 | 8.810 | 6.024 |
| Shareholders Funds | - | - | - | - | - | 2.382 | 41.278 | 88.466 | 139.994 | 160.654 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 9.659 | 44.672 | 47.953 | 265.586 | 342.438 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Proelitis Center S.r.l.